Olgu Sunumu
BibTex RIS Kaynak Göster

Çocukluk çağında paratiroid hormon bağımlı hiperkalsemi: üç olgu nedeni ile

Yıl 2021, , 28 - 34, 23.03.2021
https://doi.org/10.47582/jompac.823761

Öz

Ciddi çocukluk çağı hiperkalsemisi, düzeltilmediği takdirde koma ve ölümle sonuçlanabilen ciddi bir bulgudur. Öte yandan etiyoloji ve tedavi yaklaşımları yaşa göre değişkenlik göstermektedir. Bu nedenle tanının doğru ve ivedilikle konulması önem arz eder. Ciddi çocukluk çağı hiperkalsemisi, düzeltilmediği takdirde koma ve ölümle sonuçlanabilen ciddi bir bulgudur. Öte yandan etiyoloji ve tedavi yaklaşımları yaşa göre değişkenlik göstermektedir. Bu nedenle tanının doğru ve ivedilikle konulması önem arz eder. Bu yazıda, hiperkalsemi saptanan üç farklı olguda tanı ve tedavi yaklaşımlarının literatür eşliğinde sunulması uygun görülmüştür.

Destekleyen Kurum

-

Proje Numarası

-

Teşekkür

-

Kaynakça

  • Sadiq NM, Naganathan S, Badireddy M. Hypercalcemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.
  • Stokes VJ, Nielsen MF, Hannan FM, et al. Hypercalcemic disorder in children. J Bone Miner Res 2017; 32: 2157-70.
  • Hochberg Z. Practical Algorithms in Pediaric Endocrinology. 3rd ed. Haifa: Karger: 2017. pp 68-9.
  • Riccardi D, Brown EM. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol 2010; 298: F485-99.
  • Shah VN, Chagot B, Chazin WJ. Calcium-dependent regulation of ion channels. calcium bind proteins 2006; 1: 203-12
  • Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008; 22: 129-48.
  • Diaz-Soto G, Rocher A, Garcia-Rodriguez C, et all. The calcium sensing receptor in health and disease. Int Rev Cell Mol Biol 2016; 327: 321-69.
  • Dutta A, Pal R, Jain N, et al. Pediatric parathyroid carcinoma: a case report and review of literature. J Endocr Soc 2019; 3: 2224-35.
  • Hirai T, Nakashima A, Takasugi N, et al. Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients. Ther Apher Dial 2010; 14: 577-82.
  • Davies JH. Approach to the child with hypercalcemia. Endocr Dev. Basel, Karger, 2015, vol 28, pp 101-118
  • Benaderet AD, Burton AM, Clifton-Bligh R, et al. Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl. J Clin Endocrinol Metab 2011; 96: 2325-9.
  • Roizen J, Levine MA. Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc 2012; 75: 425-34.
  • Caldwell L, Vora A, Oo Y. Role of genetic screening for FHH in a patient with hypercalcemia and hyperparathyroidism. J Endocr Soc 2019; 3: SAT-504.
  • Tosur M, Lopez ME, Paul DL. Primary hyperparathyroidism versus familial hypocalciuric hypercalcemia: a challenging diagnostic evaluation in an adolescent female. Ann Pediatr Endocrinol Metab 2019; 24: 195-8.
  • Lee JY, Shoback SM. Familial hypocalciuric hypercalcemia and related disorders. Best Pract Res Clin Endocrinol Metab 2018; 32: 609-19.
  • Taki K, Kogai T, Sakumoto J, et al. Familial hypocalciuric hypercalcemia with a de novo mutation of calcium-sensing receptor. Endocrinol Diabetes Metab Case Rep 2015; 2015: 150016.
  • Nesbit MA, Hannan FM, Howles SA, et al. Mutation affecting G-protein subunit a11 in hypercalcemia and hypocalcemia. N Engl J Med 2013 Jun 27; 368(26): 2476-86.
  • Vahe C, Benomar K, Espiard S, et al. Diseases associated with calcium sensing receptor. Orphanet J Rare Dis 2017; 12: 19.
  • Stratta P, Merlotti G, Musetti C, et al. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel ınactivating mutations in an Italian population. Nephrol Dial Transplant 2014; 29: 1902-9.
  • Lopez CA, Anton-Martin P, Gil-Fornuer B, et al. Familial hypocalciuric hypercalcemia: new mutation in the CASR Gene converting Valine 697 to Methionine. Eur J Pediatr 2012; 171: 147-50.
  • Szalat A, Shpitzen S, Tsur A, et al. Stepwise CaSR, Ap2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia. Endocrine 2017; 55: 741-7.
  • Alon US, VanDeVoorde RG. Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr Nephrol 2010; 25: 1747-50.
  • Marx SJ. Calcimimetic use in familial hpyocalciuric hypercalcemia- a perspective in endocrinology. J Clin Endocrinol Metab 2017; 102: 3933-6.

Parathyroid hormone dependent hypercalcemia in childhood; due to three cases

Yıl 2021, , 28 - 34, 23.03.2021
https://doi.org/10.47582/jompac.823761

Öz

Severe childhood hypercalcemia appears as a serious finding that can result in coma and death if not corrected. On the other hand, etiology and treatment approaches vary according to age. Therfore it is important to make the diagnosis correctly and promptly. In this article, it was deemed appropriate to present the diagnosis and treatment approaches in three cases with different diagnosis due to hypercalcemia in the light of the literature.

Severe childhood hypercalcemia appears as a serious finding that can result in coma and death if not corrected. On the other hand, etiology and treatment approaches vary according to age. Therfore it is important to make the diagnosis correctly and promptly. In this article, it was deemed appropriate to present the diagnosis and treatment approaches in three cases with different diagnosis due to hypercalcemia in the light of the literature.

Proje Numarası

-

Kaynakça

  • Sadiq NM, Naganathan S, Badireddy M. Hypercalcemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.
  • Stokes VJ, Nielsen MF, Hannan FM, et al. Hypercalcemic disorder in children. J Bone Miner Res 2017; 32: 2157-70.
  • Hochberg Z. Practical Algorithms in Pediaric Endocrinology. 3rd ed. Haifa: Karger: 2017. pp 68-9.
  • Riccardi D, Brown EM. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol 2010; 298: F485-99.
  • Shah VN, Chagot B, Chazin WJ. Calcium-dependent regulation of ion channels. calcium bind proteins 2006; 1: 203-12
  • Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008; 22: 129-48.
  • Diaz-Soto G, Rocher A, Garcia-Rodriguez C, et all. The calcium sensing receptor in health and disease. Int Rev Cell Mol Biol 2016; 327: 321-69.
  • Dutta A, Pal R, Jain N, et al. Pediatric parathyroid carcinoma: a case report and review of literature. J Endocr Soc 2019; 3: 2224-35.
  • Hirai T, Nakashima A, Takasugi N, et al. Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients. Ther Apher Dial 2010; 14: 577-82.
  • Davies JH. Approach to the child with hypercalcemia. Endocr Dev. Basel, Karger, 2015, vol 28, pp 101-118
  • Benaderet AD, Burton AM, Clifton-Bligh R, et al. Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl. J Clin Endocrinol Metab 2011; 96: 2325-9.
  • Roizen J, Levine MA. Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc 2012; 75: 425-34.
  • Caldwell L, Vora A, Oo Y. Role of genetic screening for FHH in a patient with hypercalcemia and hyperparathyroidism. J Endocr Soc 2019; 3: SAT-504.
  • Tosur M, Lopez ME, Paul DL. Primary hyperparathyroidism versus familial hypocalciuric hypercalcemia: a challenging diagnostic evaluation in an adolescent female. Ann Pediatr Endocrinol Metab 2019; 24: 195-8.
  • Lee JY, Shoback SM. Familial hypocalciuric hypercalcemia and related disorders. Best Pract Res Clin Endocrinol Metab 2018; 32: 609-19.
  • Taki K, Kogai T, Sakumoto J, et al. Familial hypocalciuric hypercalcemia with a de novo mutation of calcium-sensing receptor. Endocrinol Diabetes Metab Case Rep 2015; 2015: 150016.
  • Nesbit MA, Hannan FM, Howles SA, et al. Mutation affecting G-protein subunit a11 in hypercalcemia and hypocalcemia. N Engl J Med 2013 Jun 27; 368(26): 2476-86.
  • Vahe C, Benomar K, Espiard S, et al. Diseases associated with calcium sensing receptor. Orphanet J Rare Dis 2017; 12: 19.
  • Stratta P, Merlotti G, Musetti C, et al. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel ınactivating mutations in an Italian population. Nephrol Dial Transplant 2014; 29: 1902-9.
  • Lopez CA, Anton-Martin P, Gil-Fornuer B, et al. Familial hypocalciuric hypercalcemia: new mutation in the CASR Gene converting Valine 697 to Methionine. Eur J Pediatr 2012; 171: 147-50.
  • Szalat A, Shpitzen S, Tsur A, et al. Stepwise CaSR, Ap2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia. Endocrine 2017; 55: 741-7.
  • Alon US, VanDeVoorde RG. Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr Nephrol 2010; 25: 1747-50.
  • Marx SJ. Calcimimetic use in familial hpyocalciuric hypercalcemia- a perspective in endocrinology. J Clin Endocrinol Metab 2017; 102: 3933-6.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Case Report [en] Olgu Sunumu [tr]
Yazarlar

Kübra Deretarla Bu kişi benim 0000-0002-9478-1463

Ayça Törel Ergür 0000-0002-7792-1727

Arzu Pampal 0000-0002-3889-990X

Esin Kaymaz 0000-0003-4127-6559

Proje Numarası -
Yayımlanma Tarihi 23 Mart 2021
Yayımlandığı Sayı Yıl 2021

Kaynak Göster

AMA Deretarla K, Törel Ergür A, Pampal A, Kaymaz E. Çocukluk çağında paratiroid hormon bağımlı hiperkalsemi: üç olgu nedeni ile. J Med Palliat Care / JOMPAC / Jompac. Mart 2021;2(1):28-34. doi:10.47582/jompac.823761

images?q=tbn:ANd9GcRrI_RWgGRe7JRpz3PAnkt2YEFD2l6WEmgHMzuM2w9b&s

f9ab67f.png     

7yziemq.png




COPE.jpg

icmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.png

images?q=tbn:ANd9GcQk2AsOdjP67NBkYAqd8FHwCmh0_3dkMrXh3mFtfPKXwIai7h0lIds8QYM9YjKMhZw8iP0&usqp=CAU

logo_world_of_journals_no_margin.png1280px-WorldCat_logo.svg.png                             images?q=tbn:ANd9GcRrI_RWgGRe7JRpz3PAnkt2YEFD2l6WEmgHMzuM2w9b&s


Dergimiz; TR-Dizin ULAKBİM, ICI World of  Journal's, Index Copernicus, Directory of Research Journals Indexing (DRJI), General Impact Factor, Google Scholar, Researchgate, WorldCat (OCLC), CrossRef (DOI), ROAD, ASOS İndeks, Türk Medline İndeks, Eurasian Scientific Journal Index (ESJI) ve Türkiye Atıf Dizini'nde indekslenmektedir.

EBSCO, DOAJ, OAJI, ProQuest dizinlerine müracaat yapılmış olup, değerlendirme aşamasındadır.

Makaleler "Çift-Kör Hakem Değerlendirmesi”nden geçmektedir.

Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN].

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser.  About predatory/questionable journals and journal charge policy

Not: Dergimiz WOS indeksli değildir ve bu nedenle Q  sınıflamasına dahil değildir.
Yağmacı/şüpheli dergilerle ilgili Yüksek Öğretim Kurumu (YÖK) kararları ve yazar açıklama metni ile dergi ücret politikası: Yağmacı/Şaibeli Dergiler ve Dergi Ücret Politikası